INDV Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 02, 2026

Report Source: 2025 Annual Report

Indivior Pharmaceuticals, Inc

Indivior Pharmaceuticals, Inc. Stock Analysis INDV

United States Health Care Mid Cap Report:
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The company sells its products in the United States and in other selected areas of the world.
Read More

Indivior Pharmaceuticals, Inc (INDV) Chart

Key Statistics of Indivior Pharmaceuticals, Inc (INDV)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$36.62$37.90

Today's Open

$37.51

Volume

1.82M

P/E Ratio (TTM)

21.34

52 Week Range

$10.63$41.00

Market Cap

4.83B

Avg. Volume

2.24M

Dividend Yield

-

Financial Metrics & Statements of Indivior Pharmaceuticals, Inc (INDV)

FAQ's for Indivior Pharmaceuticals, Inc (INDV)

  • According to Musaffa’s Shariah screening methodology, Indivior Pharmaceuticals, Inc (INDV) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.